Literature DB >> 16151770

Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?

Torbjörn Sundström1, Eva Elgh, Anne Larsson, Birgitta Näsman, Lars Nyberg, Katrine A Riklund.   

Abstract

PURPOSE: Alzheimer's disease (AD) is a primary degenerative disease that progressively affects all brain functions, with devastating consequences for the patient, the patient's family and society. Rest regional cerebral blood flow (rCBF) could have a strategic role in differentiating between AD patients and normal controls, but its use for this purpose has a low discriminatory capacity. The purpose of this study was to evaluate whether the diagnostic sensitivity of rCBF single-photon emission computed tomography (SPECT) could be increased by using an episodic memory task provocation, i.e. memory-provoked rCBF-SPECT (MP-SPECT).
METHODS: Eighteen persons (73.2+/-4.8 years) with mild AD and 18 healthy elderly (69.4+/-3.9 years) were included in the study. The subjects were injected with (99m)Tc-hexamethylpropylene amine oxime (HMPAO) during memory provocation with faces and names, followed by an rCBF-SPECT study. The rCBF (99m)Tc-HMPAO SPECT images were analysed using statistical parametric mapping (SPM2). Peaks with a false discovery rate corrected value of 0.05 were considered significant.
RESULTS: On MP-SPECT, the AD group showed a significant rCBF reduction in the left parietal cortex in comparison with healthy elderly. At rest, no significant group differences were seen.
CONCLUSION: Memory provocation increased the sensitivity of rCBF-SPECT for the detection of AD-related blood flow changes in the brain at the group level. Further studies are needed to evaluate MP-SPECT as a diagnostic tool at the individual level. If a higher sensitivity for AD at the individual level is verified in future studies, a single MP-SPECT study might be sufficient in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151770     DOI: 10.1007/s00259-005-1874-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  51 in total

1.  Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.

Authors:  Flavio Nobili; Andrea Brugnolo; Piero Calvini; Francesco Copello; Caterina De Leo; Nicola Girtler; Silvia Morbelli; Arnoldo Piccardo; Paolo Vitali; Guido Rodriguez
Journal:  Clin Neurophysiol       Date:  2005-02       Impact factor: 3.708

2.  A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation.

Authors:  J Hoffmann; C Twiesselmann; M P Kummer; P Romagnoli; V Herzog
Journal:  Eur J Cell Biol       Date:  2000-12       Impact factor: 4.492

3.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  L Fratiglioni; L J Launer; K Andersen; M M Breteler; J R Copeland; J F Dartigues; A Lobo; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

4.  The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.

Authors:  N A Lassen; A R Andersen; L Friberg; O B Paulson
Journal:  J Cereb Blood Flow Metab       Date:  1988-12       Impact factor: 6.200

5.  A transmission-dependent method for scatter correction in SPECT.

Authors:  S R Meikle; B F Hutton; D L Bailey
Journal:  J Nucl Med       Date:  1994-02       Impact factor: 10.057

6.  Single-word auditory stimulation and regional cerebral blood flow as studied by SPECT.

Authors:  D Beversdorf; S Metzger; D Nelson; R Alonso; J Kight
Journal:  Psychiatry Res       Date:  1995-09-29       Impact factor: 3.222

7.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  A Lobo; L J Launer; L Fratiglioni; K Andersen; A Di Carlo; M M Breteler; J R Copeland; J F Dartigues; C Jagger; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

8.  Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease.

Authors:  L Bäckman; J L Andersson; L Nyberg; B Winblad; A Nordberg; O Almkvist
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

9.  Basal and activational 99Tcm-HMPAO brain SPECT in Alzheimer's disease.

Authors:  E Sayit; G Yener; G Capa; T Ertay; B Keskin; S Fadiloglu; H Durak
Journal:  Nucl Med Commun       Date:  2000-08       Impact factor: 1.690

10.  Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.

Authors:  Marta Encinas; Ramón De Juan; Alberto Marcos; Pedro Gil; Ana Barabash; Cristina Fernández; Carmen De Ugarte; José Antonio Cabranes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-15       Impact factor: 9.236

View more
  2 in total

1.  PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- against.

Authors:  Alberto Pupi; Flavio Mariano Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Functional imaging studies of cognition using 99mTc-HMPAO SPECT: empirical validation using the n-back working memory paradigm.

Authors:  Catherine Ludwig; Christian Chicherio; Luc Terraneo; Pierre Magistretti; Anik de Ribaupierre; Daniel Slosman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-11       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.